Mary Ziegler

Guggenheim '23/law prof/historian/6 books, including $ for Life, and Roe, Bylines @nytimes/@latimes/@slate.

[Mary Ziegler @maryrziegler]

As we posted today at Balkinization, Reva Siegel and I updated our forthcoming piece in the Texas Law Review to account for the Court's recent ruling in B.P.J. and what comes next. Hope you have a chance to read.
https://t.co/mgUYPCmOBr

https://t.co/3LP94xzauf

[Mary Ziegler @maryrziegler]

Honored to be among the new members elected to the American Law Institute--now 63% of my faculty belongs. :)

[Mary Ziegler @maryrziegler]

Also noteworthy that Marty Makary was forced out at FDA, and so the question of mifepristone will likely remain unsettled as this case continues

[Chris “Law Dork” Geidner @chrisgeidner]

BREAKING: SCOTUS stays the Fifth Circuit's mifepristone stay order, keeping mifepristone available on current terms.

Thomas and Alito file separate dissents.

Background: https://t.co/aXjGQejOiA

[Mary Ziegler @maryrziegler]

Justice Thomas's laser focus on the Comstock Act is noteworthy

[SCOTUSblog @SCOTUSblog]

NEW: Court allows mail access to abortion pill for now. Justices Thomas and Alito dissented.

https://t.co/Ek6wbuT0M7

[Mary Ziegler @maryrziegler]

Truly weird that we don't have anything from SCOTUS, but the Fifth Circuit ruling now seems to be in effect.

[Ed Whelan @EdWhelanEPPC]

Well, it's 5 pm, so Justice Alito's administrative stay of Fifth Circuit ruling on mifepristone has expired.

[Mary Ziegler @maryrziegler]

Party realignment is such a huge part of post-Roe history, although its causes are more complicated than just reaction to Roe. Given that we are waiting on a decision from SCOTUS on the 5 CA's mifepristone ruling today, interesting to contemplate where parties are headed now.

[Ryan Burge 📊 @ryanburge]

Today, being politically conservative is synonymous with being pro-life.

That wasn't the case at all right after Roe.

In 1977, the ideological gap between pro-life/pro-choice was 5 points or less among Christian groups.

It's a chasm, now.
48 points among mainline Prots!

[Mary Ziegler @maryrziegler]

Very grateful to @lsolum for highly recommending my latest with Reva Siegel, which forthcoming in the Texas Law Review!

[Lawrence Solum @lsolum]

Highly recommended: Siegel & Ziegler, Dismantling Equality Rights Through "Biological-Sex" Talk. https://t.co/AVUGIcgdmE

[Mary Ziegler @maryrziegler]

Very grateful to @lsolum for highly recommending my latest with Reva Siegel, forthcoming in Texas Law Review.

[Lawrence Solum @lsolum]

Highly recommended: Siegel & Ziegler, Dismantling Equality Rights Through "Biological-Sex" Talk. https://t.co/AVUGIcgdmE

[Dennis J. Wieboldt III @DennisWieboldt]

Happy to share the final version of my @CreightonLawRev article, "The Dormant Commerce Clause's Lessons for Religious Exemptions." Thanks to many friends and mentors for their help on earlier drafts! Available on SSRN: https://t.co/kqsqnpnqja.

[Mary Ziegler @maryrziegler]

@CCamosy Congratulations!

[Mary Ziegler @maryrziegler]

The question is *how much* of an issue, & whether there is 1) any action in court on one of many cases involving mifepristone/interstate conflict; 2) movement in the Trump Admin; 3) a major new state development, like the abolitionist bill in SC. The issue isn't going away.

[Grace Panetta @grace_panetta]

New from me: Abortion isn't the top issue in 2026 — but Democratic & liberal candidates in state Supreme Court races in WI & GA this spring and in some upcoming House primaries are still running on it (link in replies)

[Mary Ziegler @maryrziegler]

This is an important first appraisal of Biden's time in office, with an all-star group of historian contributors, edited by @julianzelizer. Hope you get a chance to read!

[Yale Law School @YaleLawSch]

Professor @JohnFabianWitt is among the leading historians offering a first assessment of the Biden presidency in a new book.
https://t.co/WuMBMX6Krr

[Mary Ziegler @maryrziegler]

There were signs that Judge David Joseph thought Louisiana had standing and is right about the dangers of mifepristone. So this was less about siding with the Trump than it was giving the admin more time. After the midterm, if not before, all bets are off.

[Alice Miranda Ollstein @AliceOllstein]

BREAKING: A judge just sided with the Trump admin in a major case about regulation of abortion pills, putting on pause Louisiana's attempt to get national restrictions on the drugs while the FDA conducts a review. This means nothing changes for now. https://t.co/KcETbpKLZM

[Mary Ziegler @maryrziegler]

@joshjcraddock Also a pretty amazing streak for @ADFLegal

[Mary Ziegler @maryrziegler]

So honored to be 1 of 2 winners of the Organization of American Historians Prize for Contributions to Public Policy, which recognizes scholars who have made "a significant contribution to U.S. public policy through historical research." Learn more here: https://t.co/gdMLYsVr9d

[Mary Ziegler @maryrziegler]

Another important recent piece on this, forthcoming in the Penn Law Rev by Greer Donley and Chip Carter, is also now up on SSRN.

[Josh Craddock @joshjcraddock]

I’m flattered that a tenured Yale Law School professor has taken aim at my 2017 student note in her latest article. While I think her critique ultimately misses the mark, I always appreciate thoughtful engagement with my scholarship!

[Mary Ziegler @maryrziegler]

Having written on the recent struggle for personhood, I find it super interesting to see this debate about originalist arguments unfold. I'd encourage everyone to read both papers and decide for themselves.

[Josh Craddock @joshjcraddock]

I’m flattered that a tenured Yale Law School professor has taken aim at my 2017 student note in her latest article. While I think her critique ultimately misses the mark, I always appreciate thoughtful engagement with my scholarship!

[Mary Ziegler @maryrziegler]

@AbolitionistFAA Thanks for the clarification. :)

[Mary Ziegler @maryrziegler]

The FDA's explanation of its decision here is legally correct, but the fact remains that this move--and the lack of other action on mifepristone from the Trump Administration--suggests that the president feels no pressure to please pro-life groups.

[The New York Times @nytimes]

Breaking News: The FDA approved a generic version of the abortion pill mifepristone, expanding the supply at a time when the Trump administration is under pressure from abortion opponents to sharply restrict access to the pills. https://t.co/mO6DQzKwok

[Mary Ziegler @maryrziegler]

J. Kacsmaryk is sending this major abortion case to the Eastern Dist of MO). The Trump Administration argued that the original plaintiffs don't have standing, and this outcome--more delay with the later possibility of a big pro-life win--may suit them.

https://t.co/71jOMOgnhK